Highlights of the San Antonio Breast Cancer Symposium 2015: Part 1

John R. Benson, Ismail Jatoi

Research output: Contribution to journalArticlepeer-review

2 Scopus citations


38th San Antonio Breast Cancer Symposium, San Antonio, TX, USA, 8-12 December 2015 The 38th annual San Antonio Breast Cancer Symposium (SABCS) was convened in San Antonio (TX, USA) on 8-12 December 2015. More than 7000 clinicians and scientists from around the world participated in the symposium, which featured a range of presentations and keynote talks pertaining to breast cancer screening, prevention, loco-regional and systemic therapies. This two-part report highlights a selection of important studies presented at this premier breast cancer event with part 1 focusing on radiotherapy treatment, translational approaches to immunotherapy and longer term cardiotoxicity from anti-HER2 therapies. The second part of this report will discuss a range of topics including de-escalation of chemotherapy regimens in luminal A tumors, the prognostic relevance of circulating tumor cells, the optimum treatment of triple-negative breast cancer and shifting attitudes to primary surgical treatment.

Original languageEnglish (US)
Pages (from-to)893-896
Number of pages4
JournalFuture Oncology
Issue number7
StatePublished - Apr 2016


  • San Antonio
  • breast-conserving surgery
  • mastectomy
  • radiation treatment
  • triple-negative cancer

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'Highlights of the San Antonio Breast Cancer Symposium 2015: Part 1'. Together they form a unique fingerprint.

Cite this